TY - JOUR T1 - Using human-centred design to develop an innovative female condom JF - BMJ Innovations JO - BMJ Innov SP - 399 LP - 406 DO - 10.1136/bmjinnov-2020-000534 VL - 7 IS - 2 AU - Patricia S Coffey AU - Maggie Kilbourne-Brook Y1 - 2021/04/01 UR - http://innovations.bmj.com/content/7/2/399.abstract N2 - Objective The female condom is a non-hormonal barrier method that can protect from unintended pregnancy and sexually transmitted infections such as HIV. Female condoms are an important contribution to women’s reproductive health globally as they are the only woman-initiated method currently available that can provide dual protection. This article describes how human-centred design (HCD) was applied to the development of the Woman’s Condom—a second-generation female condom.Methods A multidisciplinary team pioneered the application of HCD principles to develop a novel reproductive health product. The Woman’s Condom design incorporated feedback from both female and male users from multiple sites in the USA and Cuernavaca, Mexico; Durban, South Africa and Khon Kaen, Thailand to inform product development.Results We developed and tested more than 50 design iterations reflecting various solutions to user-related concerns. The final locked design confirmed that the Woman’s Condom was easy to use, stable, comfortable and provided satisfactory sensation during sex for both partners. The ‘dissolving capsule’ to facilitate insertion and ‘soft cling’ design are key innovative features of the Woman’s Condom.Conclusion The Woman’s Condom is a second-generation female (or internal) condom product that has been shown to be highly acceptable to users throughout the world. The Woman’s Condom’s special design features enable easy insertion, secure fit during use, good sensation and easy removal. Engaging users as codesigners through an HCD approach resulted in a female condom that meets the needs of women and men from diverse regions.Data sharing not applicable as no datasets generated and/or analysed for this study. ER -